Cidara Therapeutics Inc (CDTX) — Strategic Asset Allocation Index
Cidara Therapeutics Inc (CDTX) has a Strategic Asset Allocation Index of 11.9% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $50.16 Million) total $50.16 Million, measured against net assets of $422.39 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check CDTX tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Cidara Therapeutics Inc Strategic Asset Allocation Index (2014–2021)
This chart shows how Cidara Therapeutics Inc's Strategic Asset Allocation Index has evolved across 8 annual periods from 2014 to 2021. As of September 2025, the index stands at 11.9%, representing strategic assets of $50.16 Million against net assets of $422.39 Million USD.
Annual Strategic Asset Allocation Index for Cidara Therapeutics Inc (2014–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Cidara Therapeutics Inc from 2014 to 2021, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CDTX stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 11.8% | $2.54 Million | $2.54 Million | $- | $21.57 Million | ▲ +8.6 pp |
| 2020 | 3.2% | $342.00K | $342.00K | $- | $10.71 Million | ▲ +2.1 pp |
| 2019 | 1.1% | $429.00K | $429.00K | $- | $37.84 Million | ▼ -0.1 pp |
| 2018 | 1.2% | $712.00K | $712.00K | $- | $59.14 Million | ▼ -0.5 pp |
| 2017 | 1.7% | $1.04 Million | $1.04 Million | $- | $59.74 Million | ▲ +0.2 pp |
| 2016 | 1.6% | $1.37 Million | $1.37 Million | $- | $88.18 Million | ▼ -0.1 pp |
| 2015 | 1.6% | $1.68 Million | $1.68 Million | $- | $103.91 Million | ▼ -2.5 pp |
| 2014 | 4.1% | $863.00K | $863.00K | $- | $21.10 Million | — |